During the past decade, National Heart and Lung Institute, Imperial College London conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Heart and Lung Institute, Imperial College London" #1 sponsor was "Imperial College London" with 18 trials, followed by "National Heart and Lung Institute" with 3 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Enzymatica AB" with 1 trials sponsored and "Euro CTO Club" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Heart and Lung Institute, Imperial College London" #1 collaborator was "Royal Brompton & Harefield NHS Foundation Trust" with 3 trials as a collaborator, "Medical Research Council" with 2 trials as a collaborator, "Asahi Intecc Co., Ltd." with 1 trials as a collaborator, "Biosensors International" with 1 trials as a collaborator and "British Heart Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "National Heart and Lung Institute, Imperial College London" are "COPD" (5 trials), "Asthma" (4 trials), "Pulmonary Disease, Chronic Obstructive" (3 trials), "Sleep Apnea Syndromes" (2 trials) and "Allergic Rhinitis" (1 trials). Many other conditions were trialed in "National Heart and Lung Institute, Imperial College London" in a lesser frequency.

Most popular intervention types in "National Heart and Lung Institute, Imperial College London" are "Procedure" (9 trials), "Other" (6 trials), "Behavioral" (3 trials), "Device" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nasal allergen challenge" (2 trials), "Nasal filter paper placement" (2 trials), "12-lead ECG" (1 trials), "Active muscle stimulation" (1 trials) and "Additional specific letter written to patient" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Heart and Lung Institute, Imperial College London" are 21 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Heart and Lung Institute, Imperial College London". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in National Heart and Lung Institute, Imperial College London, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in National Heart and Lung Institute, Imperial College London, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".